Panton-Valentine Leucocidin-related disease in England and Wales

Clin Microbiol Infect. 2010 Jan;16(1):86-8. doi: 10.1111/j.1469-0691.2009.02887.x.

Abstract

Within the framework of the Health Protection Agency's programme of enhanced surveillance of Staphylococcus aureus with Panton-Valentine Leucocidin (PVL-SA) in England and Wales conducted during 2005-2006, we identified 720 PVL-SA, representing a two-fold increase between 2005 (n = 224) and 2006 (n = 496). The number of PVL-methicillin-resistant S. aureus rose from 119 to 159 in that period. Isolates were referred by 112 centres and included outbreaks of PVL-related disease in community and healthcare settings. One hundred individuals had systemic disease symptoms. Planned systematic surveillance-based studies aim to better address the question of whether these increases reflect an increasing prevalence of PVL-SA and/or improved case ascertainment of PVL-related syndromes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Bacterial Toxins / metabolism*
  • Child
  • Child, Preschool
  • England / epidemiology
  • Exotoxins / metabolism*
  • Female
  • Humans
  • Infant
  • Leukocidins / metabolism*
  • Male
  • Methicillin-Resistant Staphylococcus aureus / metabolism
  • Middle Aged
  • Staphylococcal Infections / epidemiology
  • Staphylococcal Infections / microbiology*
  • Staphylococcus aureus / metabolism*
  • Wales / epidemiology

Substances

  • Bacterial Toxins
  • Exotoxins
  • Leukocidins
  • Panton-Valentine leukocidin